HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inclusion Conjunctivitis

An infection of the eyes characterized by the presence in conjunctival epithelial cells of inclusion bodies indistinguishable from those of trachoma. It is acquired by infants during birth and by adults from swimming pools. The etiological agent is CHLAMYDIA TRACHOMATIS whose natural habitat appears to be the genito-urinary tract. Inclusion conjunctivitis is a less severe disease than trachoma and usually clears up spontaneously.
Also Known As:
Conjunctivitis, Inclusion; Blennorrheas, Inclusion; Conjunctivitides, Inclusion; Inclusion Blennorrhea; Inclusion Blennorrheas; Inclusion Conjunctivitides; Blennorrhea, Inclusion
Networked: 63 relevant articles (3 outcomes, 5 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Reinfection
2. Trachoma
3. Infections
4. Lymphogranuloma Venereum
5. Eye Infections

Experts

1. Chen, Chien-Chin: 1 article (01/2022)
2. Lee, Wan-Ju Annabelle: 1 article (01/2022)
3. Andrianopoulos, Konstantinos: 1 article (12/2013)
4. Georgalas, Ilias: 1 article (12/2013)
5. Georgopoulos, Gerasimos: 1 article (12/2013)
6. Malamos, Panagiotis: 1 article (12/2013)
7. Markomichelakis, Nikos N: 1 article (12/2013)
8. Rallis, Konstantinos: 1 article (12/2013)
9. Theodossiadis, Panagiotis: 1 article (12/2013)
10. Vergados, Ioannis: 1 article (12/2013)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Inclusion Conjunctivitis:
1. AntibodiesIBA
2. Membrane Proteins (Integral Membrane Proteins)IBA
3. AntigensIBA
4. Cycloheximide (Cicloheximide)IBA
5. Indicators and Reagents (Reagents)IBA
6. Immune Sera (Antisera)IBA
7. Immunoglobulin M (IgM)IBA
8. Estradiol (Delestrogen)FDA LinkGeneric
9. SuspensionsIBA
10. Immunoglobulin G (IgG)IBA

Therapies and Procedures

1. Therapeutics